Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, ...
Happy Thanksgiving from my home to yours, sharing a little thrifting joy. BBC apologizes to Trump over editing blunder, rejects defamation claim AC/DC Shook Melbourne So Hard Earthquake-Detectors ...
WASHINGTON, Oct. 22, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2025 on Wednesday, October 29, 2025, after the ...